2891. Nebulized Phage Therapy for Patients with Cystic Fibrosis with Chronic Pseudomonas aeruginosa Pulmonary Infection: A Phase 1b/2a Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

BACKGROUND: Pseudomonas aeruginosa (PsA) continues to cause difficult-to-treat pulmonary infections and hospitalizations in patients with cystic fibrosis (CF). Safer and targeted therapies are needed to minimize the morbidity and disease burden of drug resistant PsA isolates. METHODS: This Phase 1b/...

Descripción completa

Detalles Bibliográficos
Autores principales: Rappo, Urania, Cohen, Ariel, Kario, Edith, Gold, Jenia, Nevenzal, Hadas Tamar, Levy-Saar, Inbal, Cohen, Tal, Weiner, Iddo, Livnat, Hila Sberro, Slutskin, Ilya Vainberg, Jablonska, Jagoda, Axelrod, Tim, Bahar, Ori, Buchshtab, Nufar, Lev, Vered, Tzur, Yaron, Zarchin, Yulia, Golembo, Myriam, Vilchez, Regis, Kerem, Eitan, Bassan, Merav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678098/
http://dx.doi.org/10.1093/ofid/ofad500.2474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678098/
http://dx.doi.org/10.1093/ofid/ofad500.2474

Ejemplares similares